Tumor-infiltrating CD8 + T cells showed higher proliferation (Ki67 +) and enhanced activation (CD44 +) in mRBC-240 treated mice compared with mRBC-CTRL (p = 0.044 and p = 0.034, respectively) (Fig. 5g and h). This evidence concerns the gene MKI67 and neoplasm.